CS logo
small CS logo
Japanese Red Cross Kyoto Daiichi Hospital

Kyoto, Japan
General hospital in Kyoto
15 Chome-749 Honmachi, Higashiyama Ward, Kyoto, 605-0981

About Japanese Red Cross Kyoto Daiichi Hospital


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
2
Kyoto Prefectural University of Medicine
2
Chugai Pharmaceutical
1
Hokuriku-Kinki Immunochemotherapy Study Group
1
JIMRO Co., Ltd.
1
Pfizer
1
Stryker Japan K.K.
1
Total Rows: 7

Clinical Trials at Japanese Red Cross Kyoto Daiichi Hospital


During the past decade, Japanese Red Cross Kyoto Daiichi Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11001100220000110000Started TrialsCompleted Trails201620172018201920200123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Randomized Controlled Study of Postoperative Adjuvant Therapy for Gastric Cancer Using TS-1 or TS-1+PSK
2005-03-01
2016-02-01
Completed
255
Pitavastatin on Carotid Intima-media Thickness
2007-07-01
Unknown status
300
Effects of Telmisartan on Ischemic Cardiovascular Events in High-risk Hypertensive Patients
2009-04-01
2013-07-01
Terminated
1,500
A Study To Evaluate The Safety And Efficacy Of Tofacitinib Modified Release Tablets Compared To Tofacitinib Immediate Release Tablets In Adult Patients With Rheumatoid Arthritis
2014-11-18
2017-03-15
Completed
209
Triathlon PKR Study in Japan
2013-06-01
2018-09-01
Completed
63
Thrombectomy Revascularization of Intracranial Vessel OcclusioN by Originating From Japan (TRON1-Japan)
2016-11-09
2017-10-23
Completed
50
A Study of Atezolizumab in Patients With Unresectable, Locally Advanced or Metastatic NSCLC (J-TAIL)
2018-08-15
2021-07-08
Completed
1,026
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine
2020-06-15
2025-01-31
Recruiting
1,633

Rows per page:

1–9 of 9

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Japanese Red Cross Kyoto Daiichi Hospital" #1 sponsor was "Eli Lilly and Company" with 2 trials, followed by "Kyoto Prefectural University of Medicine" with 2 trials sponsored, "Chugai Pharmaceutical" with 1 trials sponsored, "Hokuriku-Kinki Immunochemotherapy Study Group" with 1 trials sponsored and "JIMRO Co., Ltd." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Japanese Red Cross Kyoto Daiichi Hospital" #1 collaborator was "Japan Lung Cancer Society" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsEli Lilly and Company: 2Eli Lilly and Company: 2Kyoto PrefecturalUniversity of Medicine:2Kyoto PrefecturalUniversity of Medicine:2Chugai Pharmaceutical: 1Chugai Pharmaceutical: 1Hokuriku-KinkiImmunochemotherapyStudy Group: 1Hokuriku-KinkiImmunochemotherapyStudy Group: 1JIMRO Co., Ltd.: 1JIMRO Co., Ltd.: 1Pfizer: 1Pfizer: 1Stryker Japan K.K.: 1Stryker Japan K.K.: 1

Created with Highcharts 11.1.0Top CollaboratorsJapan Lung Cancer Society: 1Japan Lung Cancer Society: 1

Clinical Trials Conditions at Japanese Red Cross Kyoto Daiichi Hospital


According to Clinical.Site data, the most researched conditions in "Japanese Red Cross Kyoto Daiichi Hospital" are "Migraine" (2 trials), "Acute Coronary Syndrome" (1 trials), "Acute Ischemic Stroke" (1 trials), "Acute Myocardial Infarction" (1 trials) and "Angina Pectoris" (1 trials). Many other conditions were trialed in "Japanese Red Cross Kyoto Daiichi Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Japanese Red Cross Kyoto Daiichi Hospital


Most popular intervention types in "Japanese Red Cross Kyoto Daiichi Hospital" are "Drug" (6 trials) and "Device" (2 trials). Other intervention types were less common.
The name of intervention was led by "Lasmiditan" (2 trials), "Blopress (Candesartan)" (1 trials), "Krestin (PSK)" (1 trials), "Micardis (Telmisartan)" (1 trials) and "Pitavastatin" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Japanese Red Cross Kyoto Daiichi Hospital


The vast majority of trials in "Japanese Red Cross Kyoto Daiichi Hospital" are 9 trials for "All" genders.

Clinical Trials Status at Japanese Red Cross Kyoto Daiichi Hospital


Currently, there are NaN active trials in "Japanese Red Cross Kyoto Daiichi Hospital". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Japanese Red Cross Kyoto Daiichi Hospital, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Japanese Red Cross Kyoto Daiichi Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhaseNot Applicable: 4Not Applicable: 4Phase 3: 4Phase 3: 4

Created with Highcharts 11.1.0Trials StatusCompleted: 5Completed: 5Recruiting: 2Recruiting: 2Terminated: 1Terminated: 1Unknown status: 1Unknown status: 1